Estimation of the β+ dose to the embryo resulting from 18F-FDG administration during early pregnancy

Journal of Nuclear Medicine

Volumn 49, Issue 4, 2008, Pages 679-682

  Zanotti Fregonara, Paolo ^a   Champion, Christophe ^b   Trébossen, Régine ^a   Maroy, Renaud ^a   Devaux, Jean Yves ^c   Hindié, Elif ^d,e  

^a DIF   (France)

^b UNIVERSITÉ DE LORRAINE   (France)

^c HÔPITAL SAINT ANTOINE   (France)

^d SAINT LOUIS HOSPITAL   (France)

^e UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

18F FDG; Embryo dosimetry; Monte carlo simulation

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADULT; AMNION FLUID; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; EMBRYO; EMBRYONAL TISSUE; FEMALE; HODGKIN DISEASE; HUMAN; MEDIASTINUM MASS; MONTE CARLO METHOD; PHOTON; POSITRON EMISSION TOMOGRAPHY; PREGNANCY; PRIORITY JOURNAL; RADIATION DOSE; UTERUS;

ADULT; BETA RAYS; FEMALE; FETUS; FLUORODEOXYGLUCOSE F18; HUMANS; MONTE CARLO METHOD; POSITRON-EMISSION TOMOGRAPHY; PREGNANCY;

EID: 42049119196     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: 10.2967/jnumed.107.048900     Document Type: Article

References (29)

1. Russell JR, Stabin MG, Sparks RB, Watson E. Radiation absorbed dose to the embryo/fetus from radiopharmaceuticals. Health Phys. 1997;73:756-769.
2. Adelstein SJ. Administered radionuclides in pregnancy. Teratology. 1999;59:236-239.
3. Alibazoglu H, Kim R, Ali A, Green A, La Monica G. FDG uptake in gestational sac. Clin Nucl Med. 1997;22:557.
4. Frouin V, Comtat C, Reilhac A, Gregoire MC. Correction of partial-volume effect for PET striatal imaging: fast implementation and study of robustness. J Nucl Med. 2002;43:1715-1726.
5. Stabin MG, Sparks RB, Crowe E. OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine. J Nucl Med. 2005;46:1023-1027.
6. Doses to the embryo and fetus from intakes of radionuclides by the mother. ICRP publication 88. Ann ICRP. 2001;31(1):19.
7. O'Rahilly R, Muller F. Human Embryology and Teratology. New York, NY: Wiley-Liss; 2001.
8. Chen J. Mathematical models of the embryo and fetus for use in radiological protection. Health Phys. 2004;86:285-295.
9. Basic anatomical and physiological data for use in radiological protection: reference values - a report of age- and gender-related differences in the anatomical and physiological characteristics of reference individuals. ICRP Publication 89. Ann ICRP. 2002;32(3-4):5-265.
10. Champion C. Theoretical cross sections for electron collisions in water: structure of electron tracks. Phys Med Biol. 2003;48:2147-2168.
11. 131I in spheres of various sizes. J Nucl Med. 2007;49:151-157.
12. Champion C, Le Loirec C. Positron follow-up in liquid water: I. A new Monte Carlo track-structure code. Phys Med Biol. 2006;51:1707-1723.
13. Hervieux PA, Fojón OA, Champion C, Rivarola RD, Hanssen J. Positronium formation in collisions of fast positrons impacting on vapour water molecules. J Phys B At Mol Opt Phys. 2006;39:409-419.
14. Stabin MG, Konijnenberg MW. Re-evaluation of absorbed fractions for photons and electrons in spheres of various sizes. J Nucl Med. 2000;41:149-160.
15. 18F-FDG PET/CT examinations. J Nucl Med. 2005;46:608-613.
16. Mountford PJ. Risk assessment of the nuclear medicine patient. Br J Radiol. 1997;70:671-684.
17. 18F-FDG. J Nucl Med. 2002;43:210-214.
18. Mejia AA, Nakamura T, Masatoshi I, Hatazawa J, Masaki M, Watanuki S. Estimation of absorbed doses in humans due to intravenous administration of fluorine-18-fluorodeoxyglucose in PET studies. J Nucl Med. 1991;32:699-706.
19. Loevinger R, Budinger T, Watson E. MIRD primer for absorbed dose calculations. Reston, VA: Society of Nuclear Medicine; 1988
20. RADAR - the RAdiation Dose Assessment Resource. Stanford Dosimetry, LLC, Web site. Available at: www.doseinfo-radar.com. Accessed January 25, 2008.
21. Helmrot E, Pettersson H, Sandborg M, Alten JN. Estimation of dose to the unborn child at diagnostic X-ray examinations based on data registered in RIS/PACS. Eur Radiol. 2007;17:205-209.
22. Sgouros G. Dosimetry of internal emitters. J Nucl Med. 2005;46(suppl):18S-27S.
23. Benveniste H, Fowler JS, Rooney WD, et al. Maternal-fetal in vivo imaging: a combined PET and MRI study. J Nucl Med. 2003;44:1522-1530.
24. 18F-FDG. J Nucl Med. 2004;45:634-635.
25. Hay WW Jr. Recent observations on the regulation of fetal metabolism by glucose. J Physiol. 2006;572:17-24.
26. Dailland P, Cockshott ID, Lirzin JD, et al. Intravenous propofol during cesarean section: placental transfer, concentrations in breast milk, and neonatal effects - a preliminary study. Anesthesiology. 1989;71:827-834.
27. Steenvoorde P, Pauwels EK, Harding LK, Bourguignon M, Mariere B, Broerse JJ. Diagnostic nuclear medicine and risk for the fetus. Eur J Nucl Med. 1998;25:193-199.
28. Brix G, Lechel U, Veit R, et al. Assessment of a theoretical formalism for dose estimation in CT: an anthropomorphic phantom study. Eur Radiol. 2004;14:1275-1284.
29. Swerdlow AJ, Jacobs PA, Marks A, et al. Fertility, reproductive outcomes, and health of offspring, of patients treated for Hodgkin's disease: an investigation including chromosome examinations. Br J Cancer. 1996;74:291-296.